• Macromolecular Research
• /
• 제8권4호
• /
• pp.186-191
• /
• 2000

Clay-dispersed nanocomposites have been prepared by simple melt-mixing of three components, i.e. poly (styrene co-acrylonitrile) copolymer (SAN), poly ($\xi$-caprolactone ) (PCL), and an organophilic clay(Cloisite(R) 30A). In the present study, poly($\xi$-caprolactone) was added in the mixtures in order to facilitate the intercalation of SAN into the gallery of silicate layers, and the molecular weight effects of PCL on the dispersion of silicate layers were compared by changing the amount of added PCL. The degree of dispersion of 10-$\AA$-thick silicate layers of clay in the nanocomposites was investigated by using an X-ray diffractometer and a transmission electron microscope. It was found that PCL added in the mixture facilitate the intercalation of SAN copolymers into the galleries of silicate layers modified with an organic intercalant, resulting in the better dispersion of clay. It was, also, observed that the processing temperature influences the degree of clay dispersion.

• 폴리머
• /
• 제28권3호
• /
• pp.232-238
• /
• 2004

약물 전달체로서 메톡시 폴리(에틸렌 글리콜) (MPEG, methoxypolyethylene glycol)과 생분해성 폴리에스테르 계열의 카프로탁톤 ($\varepsilon$-CL, $\varepsilon$-caprolactone)으로 구성된 MPEG-PCL 블록 공중합체를 개환중합을 통해 합성하였다. MPEG-PCL의 결정성과 열적특성은 X선 굴절계와 시사주차열량계를 통하여 분석하였다 모델 단백질로서 알부민 (FITC-BSA, albumin bovine-fluorescein isothiocyanate)과 블록 공중합체를 동결 제분 후, 직접압축 성형방법에 의해 웨이퍼를 제조하였다. 알부민의 방출은 pH 7.4 인산염완충액을 사용하여 37$^{\circ}C$에서 14일 동안 관찰하였다. 알부민의 방출양은 형광분광기를 통하여 FITC의 강도에 의해 결정되었다. 웨이퍼의 형태학적 관찰은 디지털 카메라와 전자주사현미경을 통하여 관찰하였다. 알부민의 방출 속도와 초기 burst는 MPEG-PCL 블록 공중합체의 분절 내에서 폴리(에틸렌 글리롤)의 분자량이 증가할수록 또한 폴리카프로락톤의 분자량이 감소할수록 많은 초기방출과 단축된 방출기간을 보였다.

• Macromolecular Research
• /
• 제13권5호
• /
• pp.397-402
• /
• 2005

To explore the potential of shell crosslinked micelle (SCM) as a drug carrier, the drug release behavior of poly($\varepsilon$-caprolactone)-b-poly(acrylic acid) (PCL-b-PAA) SCMs was investigated. PCL-b-PAA was synthesized by ring opening polymerization of $\varepsilon$-caprolactone and atom transfer radical polymerization of tert-butyl acrylate, followed by selective hydrolysis of tert-butyl ester groups to acrylic acid groups. The resulting amphiphilic polymer was used to prepare SCMs by crosslinking of PAA corona via amidation chemistry. The drug release behavior of the SCMs was studied, using pyrene as a model drug, and was compared with that of non-crosslinked micelles, especially below the critical micelle concentration (CMC). When the shell layers were crosslinked, the drug release behavior of the SCMs was successfully modulated at a controlled rate compared with that of the non-crosslinked micelles, which showed a burst release of drug within a short time.

• 폴리머
• /
• 제27권5호
• /
• pp.449-457
• /
• 2003

액중건조법을 사용하여 PCL/PEO 마이크로캡슐을 제조하여 형태적 분석 및 제조 조건에 따른 특성을 살펴보고 거동을 통하여 약물 전달 체계로서의 가능성을 고찰하였다. 유화제의 종류 및 농도 그리고 교반 속도에 따른 마이크로캡슐의 입경과 형태의 변화에 대하여 광학 현미경과 SEM을 사용하여 관찰하였다. 또한 접촉각 측정을 통해 PCL/PEO와 약물간의 계면에서의 부착일을 살펴보았으며, 방출 거동을 알아보기 위해 UV/vis. 흡광 광도법으로 흡광도를 측정 하여 용출된 약물의 양을 정량하였다. 그 결과, 마이크로캡슐의 평균 입경이 170 nm∼68 $\mu$m인 구형의 형태를 나타내었으며, PEO의 함량이 증가함에 따라 친수성기가 증가하여 물에 대한 부착일이 증가함을 알 수 있었다. 또한 약물 방출 실험을 통하여 PEO의 함량을 높게 하고 교반 속도를 빠르게 하여 제조한 마이크로캡슐의 약물 방출이 상당히 빠름을 알 수 있었다 이는 PEO의 함량이 증가함에 따라 친수성기가 증가하고 계면력이 증가하기 때문이라 사료된다.

• Archives of Pharmacal Research
• /
• 제26권1호
• /
• pp.76-82
• /
• 2003

Drug releasing porous poly($\varepsilon$-caprolactone) (PCL)-chitosan matrices were fabricated for bone regenerative therapy. Porous matrices made of biodegradable polymers have been playing a crucial role as bone substitutes and as tissue-engineered scaffolds in bone regenerative therapy. The matrices provided mechanical support for the developing tissue and enhanced tissue formation by releasing active agent in controlled manner. Chitosan was employed to enhance hydrophilicity and biocompatibility of the PCL matrices. PDGF-BB was incorporated into PCL-chitosan matrices to induce enhanced bone regeneration efficacy. PCL-chitosan matrices retained a porous structure with a 100-200 $\mu$m pore diameter that was suitable for cellular migration and osteoid ingrowth. $NaHCO_3$ as a porogen was incorporated 5% ratio to polymer weight to form highly porous scaffolds. PDGF-BB was released from PCL-chitosan matrices maintaining therapeutic concentration for 4 week. High osteoblasts attachment level and proliferation was observed from PCL-chitosan matrices. Scanning electron microscopic examination indicated that cultured osteoblasts showed round form and spread pseudopods after 1 day and showed broad cytoplasmic extension after 14 days. PCL-chitosan matrices promoted bone regeneration and PDGF-BB loaded matrices obtained enhanced bone formation in rat calvarial defect. These results suggested that the PDGF-BB releasing PCL-chitosan porous matrices may be potentially used as tissue engineering scaffolds or bone substitutes with high bone regenerative efficacy.

• 폴리머
• /
• 제38권4호
• /
• pp.477-483
• /
• 2014

Poly(lactic acid) (PLA) and poly(${\varepsilon}$-caprolactone) (PCL) blends with various components for melt-blown non-wovens were prepared by a twin-screw extruder. Tributyl citrate (TBC) was added in order to improve the miscibility between PLA and PCL. The results showed that small circular particles of PCL were dispersed in PLA matrix uniformly. The addition of PCL had the heterogeneous nucleation effect on the crystallization of PLA and decreased thermal stability of PLA. The flow of pure PLA and blends approached to Newtonian liquid at a low shear rate and expressed more obvious viscoelasticity at a high shear rate.

• 폴리머
• /
• 제25권4호
• /
• pp.521-527
• /
• 2001

폴리카프로락톤 (PCL)/폴리염화비닐(PVC) 블렌드 시스템에서 PCL 조성 5 ~ 23%에 대한 상용성, 기계적 성질과 분자간의 상효작용에 대하여 연구하였다. 유리전이온도(T$_g$) 거동을 토대로 용융 혼합된 블렌드의 상용성을 측정한 결과 분자 수준으로 혼합되었다는 것을 관찰하였으며, PCL의 함량이 증가함에 따라 블렌드의 T$_g$는 낮은 온도 쪽으로 이동하였다. 또한 PCL/PVC 블렌드에 대하여 Fox식을 이용하여 예측한 T$_g$값과 실험에서 측정된 T$_g$값은 잘 일치하였다. 따라서 PCL/PVC 블렌드 시스템은 PCL 함량이 5 ~ 23%에서 무정형 고분자임을 나타낸다. 또한 분자간의 상호작용이 기계적 물성에 미치는 영향을 관찰하기 위하여 인장 강도, 탄성률 및 항복 강도와 같은 기계적 물성을 측정하여 관찰하였다. 그 결과 탄성률과 항복 강도 값은 PCL 함량이 약 5%에서, 인장 강도 값은 PCL 함량이 11%에서 최대값을 나타내었다. 그리고 PCL 함량 13%이상까지는 인장 강도 값이 순수 PVC보다 높았으며, 신장률은 낮은 값을 나타내었다. 결과적으로 PCL/PVC 블렌드 시스템은 PCL 함량이 약 13%까지 T$_g$값은 내려가고, 인장 강도는 증가하면서 신장률은 감소하는 반가소화 현상을 나타내었다.

• Advanced Composite Materials
• /
• 제17권2호
• /
• pp.157-166
• /
• 2008

In this study, multiwalled carbon nanotubes (MWCNTs) were compounded with the poly($\varepsilon$-caprolactone) (PCL) matrix at the solution state using chloroform. For homogeneous dispersion of MWCNTs in polymer matrix, oxygen-containing groups were introduced on the surface of MWCNTs. The mechanical properties of the PCL/MWCNTs composites were effectively increased due to the incorporation of MWCNTs. The composites were characterized using scanning electron microscopy in order to obtain information on the dispersion of MWCNT in the polymeric matrix. In case of 1.2 wt% of MWCNTs in the matrix, strength and modulus of the composite increased by 12.1% and 164.3%, respectively. In addition, the dispersion of MWCNTs in the PCL matrix resulted in substantial decrease of the electrical resistivity of the composites as the MWCNTs loading was increased from 0 to 2.0 wt%. Furthermore, thermal stability of the PCL and PCL/MWCNTs-COOH composites were investigated using the data acquired from the thermogravimetric analysis. The detailed kinetics of the thermal degradation of the composites was investigated by analyzing their thermal behavior at different heating rates in a nitrogen atmosphere. Activation energy of thermal degradation was determined by using the equations proposed by Kissinger and Flynn-Wall-Ozawa. The apparent activation energy of PCL/MWCNTs-COOH composite was considerably higher than that of neat PCL.

• 폴리머
• /
• 제31권2호
• /
• pp.153-159
• /
• 2007

생분해성 분자 날인 고분자는 바이오센서 약물 전달 등의 생의학적 분야에 적응이 가능하다. 그러므로, 본 연구에서는 생분해성 고분자인 $poly(\varepsilon-caprolactone)$ (PCL) 매크로머를 가교제로 사용하여 theophylline 분자 날인 고분자를 광중합을 통해 제조하고 물성을 조사하였다. PCL 매크로머는 말단에 아크릴기를 갖도록 합성하였으며 FT-IR과 $^1H-NMR$로 확인하였다. PCL 매크로머의 합성수율은 약 78 mol%였다. Theophylline의 제거 및 재결합 실험은 UV/Vis분광기를 이용하여 용액 내 theophylline의 농도를 확인함으로써 이루어졌다. Theophylline분자 날인 고분자의 생분해성 실험을 $37^{\circ}C$의 PBS 용액 내에서 진행한 결과 우수한 생분해성을 보였다.

• 대한의용생체공학회:의공학회지
• /
• 제40권1호
• /
• pp.7-14
• /
• 2019

The microencapsulation of nifedipine (NF) with 4 wt% of poly(${\varepsilon}-caprolactone$) (PCL)/polyvinylpyrollidone (PVP) or PCL/polyethylene glycol (PEG) was carried out by solvent evaporation method in oil in water emulsion system to investigate the effect of PVP and PEG addition on drug release behavior of the microcapsules. The PVA (emulsifier) concentration of 1.0 wt% was chosen for the formation of PCL capsule having an average size of $154{\pm}25{\mu}m$ due to nearly spherical shape with a narrow size distribution. As PCL/PVP and PCL/PEG ratios were raised from 10/0 to 6/4, the capsule size increased gradually from $154{\pm}25{\mu}m$ to $236{\pm}32{\mu}m$ and $248{\pm}56{\mu}m$, respectively. The drug release rate of PCL/PVP and PCL/PEG capsules increased dramatically from 0 to 4 h at the beginning and then reached the plateau region from 20 h. As the concentration of PVP or PEG increased, the amount of drug release increased, suggesting that the larger capsule size was attributed to the higher drug content. However, the drug release behavior remained almost constant. The PCL capsules exhibited no evidence of causing cell lysis or toxicity regardless of NF loading, implying that the microcapsules are clinically suitable for use as drug delivery systems.